No takes yet. Share an insight, caveat, or question.
Review discusses cadherin dysfunction and signaling pathway interactions in human and animal cancers, suggesting that cadherin-targeting therapies may suppress progression.
Kaszak et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: